Corrections to “Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression”
In: Annals of Oncology, Jg. 28 (2017), Heft 11, S. 2899
academicJournal
Zugriff:
Titel: |
Corrections to “Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression”
|
---|---|
Autor/in / Beteiligte Person: | Nitz, U. ; Gluz, O. ; Huober, J. ; Kreipe, H.H. ; Kates, R.E. ; Hartmann, A. ; Erber, R. ; Moustafa, Z. ; Scholz, M. ; Lisboa, B. ; Mohrmann, S. ; Möbus, V. ; Augustin, D. ; Hoffmann, G. ; Weiss, E. ; Böhmer, S. ; Kreienberg, R. ; Du Bois, A. ; Sattler, D. ; Thomssen, C. ; Kiechle, M. ; Jänicke, F. ; Wallwiener, D. ; Harbeck, N. ; Kuhn, W. |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 28 (2017), Heft 11, S. 2899 |
Veröffentlichung: | Elsevier BV, 2017 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 |
DOI: | 10.1093/annonc/mdw349 |
Schlagwort: |
|
Sonstiges: |
|